These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 25437821)
61. The Effect of a Novel Serine Protease Inhibitor on Inflammation and Intestinal Permeability in a Murine Colitis Transfer Model. Van Spaendonk H; Ceuleers H; Smet A; Berg M; Joossens J; Van der Veken P; Francque SM; Lambeir AM; De Man JG; De Meester I; Augustyns K; De Winter BY Front Pharmacol; 2021; 12():682065. PubMed ID: 34248633 [No Abstract] [Full Text] [Related]
62. Schistosome Infection and Schistosome-Derived Products as Modulators for the Prevention and Alleviation of Immunological Disorders. Mu Y; McManus DP; Hou N; Cai P Front Immunol; 2021; 12():619776. PubMed ID: 33692793 [TBL] [Abstract][Full Text] [Related]
69. Identifying Therapeutic Targets for Sepsis Research: A Characterization Study of the Inflammatory Players in the Cecal Ligation and Puncture Model. Nullens S; De Man J; Bridts C; Ebo D; Francque S; De Winter B Mediators Inflamm; 2018; 2018():5130463. PubMed ID: 30174555 [TBL] [Abstract][Full Text] [Related]
70. Treatment with Cestode Parasite Antigens Results in Recruitment of CCR2+ Myeloid Cells, the Adoptive Transfer of Which Ameliorates Colitis. Reyes JL; Lopes F; Leung G; Mancini NL; Matisz CE; Wang A; Thomson EA; Graves N; Gilleard J; McKay DM Infect Immun; 2016 Dec; 84(12):3471-3483. PubMed ID: 27672083 [TBL] [Abstract][Full Text] [Related]
71. A double edged sword: Schistosoma mansoni Sm29 regulates both Th1 and Th2 responses in inflammatory mucosal diseases. Oliveira SC; Figueiredo BC; Cardoso LS; Carvalho EM Mucosal Immunol; 2016 Nov; 9(6):1366-1371. PubMed ID: 27554296 [No Abstract] [Full Text] [Related]
72. The omic approach to parasitic trematode research-a review of techniques and developments within the past 5 years. Haçarız O; Sayers GP Parasitol Res; 2016 Jul; 115(7):2523-43. PubMed ID: 27126082 [TBL] [Abstract][Full Text] [Related]
73. FoxP3+ T regulatory cells and immunomodulation after Schistosoma mansoni egg antigen immunization in experimental model of inflammatory bowel disease. Hasby EA; Hasby Saad MA; Shohieb Z; El Noby K Cell Immunol; 2015 May; 295(1):67-76. PubMed ID: 25766778 [TBL] [Abstract][Full Text] [Related]
74. Schistosoma mansoni infection but not egg antigen promotes recovery from colitis in outbred NMRI mice. Bodammer P; Waitz G; Loebermann M; Holtfreter MC; Maletzki C; Krueger MR; Nizze H; Emmrich J; Reisinger EC Dig Dis Sci; 2011 Jan; 56(1):70-8. PubMed ID: 20428947 [TBL] [Abstract][Full Text] [Related]
75. Priming of the immune response by schistosome eggs. Pearce EJ Parasite Immunol; 2005; 27(7-8):265-70. PubMed ID: 16138847 [TBL] [Abstract][Full Text] [Related]
76. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Pearce EJ; M Kane C; Sun J; J Taylor J; McKee AS; Cervi L Immunol Rev; 2004 Oct; 201():117-26. PubMed ID: 15361236 [TBL] [Abstract][Full Text] [Related]
77. Treatment with egg antigens of Schistosoma mansoni ameliorates experimental colitis in mice through a colonic T-cell-dependent mechanism. Heylen M; Ruyssers NE; Nullens S; Schramm G; Pelckmans PA; Moreels TG; De Man JG; De Winter BY Inflamm Bowel Dis; 2015 Jan; 21(1):48-59. PubMed ID: 25437821 [TBL] [Abstract][Full Text] [Related]
78. Worm proteins of Schistosoma mansoni reduce the severity of experimental chronic colitis in mice by suppressing colonic proinflammatory immune responses. Heylen M; Ruyssers NE; De Man JG; Timmermans JP; Pelckmans PA; Moreels TG; De Winter BY PLoS One; 2014; 9(10):e110002. PubMed ID: 25313594 [TBL] [Abstract][Full Text] [Related]